Aavogen

United States
Barbourmeade, Kentucky, United States

Company profile

Aavogen company profile

Aavogen is a biotech startup that develops gene therapeutics for muscle wasting diseases. This includes muscular dystrophy, inflammatory myopathies and heart failure. We make you stronger.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2015-08-01, Month

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
8
Total equity funding
$475,000
Last funding
Grant / $350,000 / 2025-09-05
Last equity funding
Seed / $400,000
Investors
4
Lead investors
1
Founders
1
Articles
4

Founders and investors

Founders

Buel Rodgers

Lead investors

National Institutes of Health

Investors

Convertible Note InvestorKilpatrick Townsend & Stockton LLPNational Institutes of HealthWashington Research Foundation